|
| |
| | | | 1 | | | DO1.PCCNTR.873943 ContractData Container |
| | | 1.1 | | | | | | | | | | 31,107,874.00 | 0.00 | 0.00 | 0.00 | 31,976,374.00 | 31,971,874.00 |
|
| | | | | | | 2 | | 2.3.4.1.01 | BEVACIZUMAB 100 MG INY ( AVASTIN) | 90 | UD | 24,800 | 24,800 | 2,232,000.00 | | 0.00 | | | 0.00 | | 0.00 | 2,232,000.00 | 2,232,000.00 | |
|
| | | | | | | 3 | | 2.3.4.1.01 | BEVACIZUMAB 400 MG INY ( AVASTIN) | 76 | UD | 97,827 | 97,827 | 7,434,852.00 | | 0.00 | | | 0.00 | | 0.00 | 7,434,852.00 | 7,434,852.00 | |
|
| | | | | | | 4 | | 2.3.4.1.01 | CAPECITABINA 500 MG (XELODA) | 18,000 | UD | 174 | 173.75 | 3,127,500.00 | | 0.00 | | | 0.00 | | 0.00 | 3,132,000.00 | 3,127,500.00 | |
|
| | | | | | | 5 | | 51111618 - Metotrexato de(...)51111618 - Metotrexato de sodio |
| 2.3.4.1.01 | PERTUZUMAB 420 MG ( PERJETA ) | 10 | UD | 210,090 | 210,090 | 2,100,900.00 | | 0.00 | | | 0.00 | | 0.00 | 2,100,900.00 | 2,100,900.00 | |
|
| | | | | | | 6 | | 2.3.4.1.01 | RITUXIMAB 1,400MG/ 11.7 ML INY (MABTHERA) | 46 | UD | 78,000 | 78,000 | 3,588,000.00 | | 0.00 | | | 0.00 | | 0.00 | 3,588,000.00 | 3,588,000.00 | |
|
| | | | | | | 7 | | 2.3.4.1.01 | RITUXIMAB 100 MG / 10 ML (MABTHERA) | 128 | UD | 13,500 | 13,500 | 864,000.00 | | 0.00 | | | 0.00 | | 0.00 | 1,728,000.00 | 1,728,000.00 | |
|
| | | | | | | 8 | | 2.3.4.1.01 | RITUXIMAB 500MG /INY (MABTHERA) | 30 | UD | 67,000 | 67,000 | 2,010,000.00 | | 0.00 | | | 0.00 | | 0.00 | 2,010,000.00 | 2,010,000.00 | |
|
| | | | | | | 9 | | 2.3.4.1.01 | TRASTUZUMAB 600 MG / 5ML (HECEPTIN) | 106 | UD | 91,987 | 91,987 | 9,750,622.00 | | 0.00 | | | 0.00 | | 0.00 | 9,750,622.00 | 9,750,622.00 | |
|
|
| | | |
| | | |
|